Curis, Inc. ( CRIS) - Stock Earnings
CRIS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
CRIS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 19.4 million USD | 1.1 million USD |
| 2026Q1 | -24.2 million USD | — USD |
| 2026Q2 | -8.6 million USD | — USD |
| 2026Q4 Est. | — | — |
CRIS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -47.4 million USD | 10.0 million USD |
| 2024 | -43.4 million USD | 10.9 million USD |
| 2025 | -7.6 million USD | 9.4 million USD |
| 2026 Est. | — | — |
CRIS
Price: $0.60
52 week price:
Earnings Per Share: -396.87 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 479800
Ebitda: -14.2 millionMarket Capitalization: 1.6 million